Navigation Links
Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Date:6/26/2008

026html.htm" target="_new">http://consensus.nih.gov/2005/2005InsomniaSOS026html.htm. Accessed on

June 18, 2008.

6. D'Alonzo GE, Krachman SL. Circadian rhythm sleep disorders. JAOA.

2000;100(8):S15-21.

7. Drake CL, Roehrs T, Richardson G, Walsh JK, Roth T. Shift work sleep

disorder: prevalence and consequences beyond that of symptomatic day

workers. Sleep. 2004;27:1453-62.

8. Carney PR, Berry RB, Geyer JD, eds. Clinical Sleep Disorders.

Lippincott Williams & Wilkins, 2004.


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...irl with Hypophosphatasia Treated With ENB-0040 at...nnipeg , , MONTREAL, Dec. 1 ...ny focused on developing novel therapeutics for se...st infant patient in its clinical program for hypo...zyme Replacement Therapy (ERT) with ENB-0040 for t...
(Date:12/1/2008)...ISTGARD, Denmark, December 1 /PRNewswire-FirstCall...007 with the intent to procure an MVA-based,thir...vernment Services,Canada, on behalf of the Canadi...contract to Bavarian Nordic for the delivery of IM...d to use IMVAMUNE(R) as part of the,country,s bio...
(Date:11/30/2008)... , CHICAGO, Dec. 1 O...cerebral blood flow and a greater number of small ...presented today at the annual meeting of the Radio... The study, conducted at the University of Nort... compare brain scans of older adults who exercise ...
(Date:11/27/2008)...udy finds the majority of acute lymphoblastic leuk...nt at the time of diagnosis , , MEMPHIS, Te... at St. Jude Children,s Research Hospital have ide...cells of children with acute lymphoblastic leukemi...athway to designing treatments for ALL relapse in ...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3AMDL Inc Closes Private Placement of Convertible Notes 7718 1AMDL Inc Closes Private Placement of Convertible Notes 7718 2AMDL Inc Closes Private Placement of Convertible Notes 7718 3AMDL Inc Closes Private Placement of Convertible Notes 7718 4Simulations help explain fast water transport in nanotubes 4912 1Simulations help explain fast water transport in nanotubes 4912 2Canadian Company Sued for Defrauding Thousands of U S Consumers of Dietary Supplements 26497 1Canadian Company Sued for Defrauding Thousands of U S Consumers of Dietary Supplements 26497 2Joint Commission Urges Patients to Speak Up About Pain 3071 1Joint Commission Urges Patients to Speak Up About Pain 3071 2Joint Commission Urges Patients to Speak Up About Pain 3071 3
...ALTHAM, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Adn...esentation of the abstract,"CT-322: A specific VEG...ity in preclinical tumor models comparable to pan-...inib and sorafenib" at the,American Association fo...s Angeles, CA. The lead author is Irvith Carvajal,...
...SUNNYVALE, Calif. and LOS ANGELES, April 18, 2007,...y announced data,from two preclinical studies, one...histone deacetylase (HDAC) inhibitor and,another d...its,Bruton,s tyrosine kinase (BTK) inhibitor compo...ciation for Cancer Research (AACR),2007 Annual Mee...
Other Medicine Technology:Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5
(Date:12/1/2008)...scription meds, supplements can also trigger acute...ec. 1 (HealthDay News) -- Antibiotics are the sing... drug-induced liver injury (DILI), researchers say... of cases of acute liver failure in the United Sta...te liver failure. , DILI is caused by a wide ra...
(Date:12/1/2008)...al December push wraps up successful disaster reli...ire-USNewswire/ -- The American Red Cross is askin...s by raising $30 million in 30 days. This holiday ...illion goal for the Red Cross Campaign for Disaste...$70 million since its launch in September, and the...
(Date:12/1/2008)...XANDRIA, Va., Dec. 1 To...act, nearly 7,000 people die each day due to HIV... day of awareness and outreach to help people worl... theme for World AIDS Day 2008 is You Can Make a...ringing people together to talk about HIV as well ...
(Date:12/1/2008)... DIEGO, Dec. 1 SpectraSc...go based medical device company, today,announced ... Optical Biopsy,System for Tissue Diagnosis. , ...is patent is important to,the Company,s optical b... the,areas of tissue surveillance, characterizati...
Breaking Medicine News(10 mins):Health News:Antibiotics Largest Cause of Drug-Induced Liver Damage 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3Health News:In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia 2Health News:SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis 2
...mpany, has acquired Innovation Sports, Inc., a U.S...The acquisition of Innovation Sports comes on the ...Medical in the U.S., and the December 2005 acquisi...ese acquisitions, and its 2003 acquisition of Gene...
...ster of the Indian State of Bihar has been given t...tish Kumar, the State’s Chief Minister is reported...m the city of Patna. Sources close to Nitish Kum...ve the law and order situation in the state, but e...
...e Cancer Center – Arthur G. James Cancer Hospital ...nd a tumor suppressor gene that could be of vital ...ancers as well as lung cancer. //Their study shows...he development of the aforementioned cancers.<...
...staff, it has been proposed to extend the Medicare... currently played by nurses, podiatrist surgeons a...her extended to accomodate them into vacant postit...rom doctors and other health professionals. The pr...
Other Medicine News:Health News:Ossur Acquires the U.S. Orthopaedics Company 2Health News:Unusual Tumor-Suppressor Gene Switches Off in Lung Cancer 2Health News:Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals 2
The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade.
Low-profile hand-held instruments.
The BioPro Basal Thumb joint is manufactured from Cobalt Chrome and is used to replace the Trapeziometacarpal joint.
Anatomic implant shape and easy-to use instrumentation promote implant alignment, stability, and restored joint kinematics.
Medicine Products: